Dr. Linda M Boxer M.D.?
Update this Profile
Dr. Linda M Boxer M.D., Hematologist (Blood Specialist)
We verify the medical license of each FindaTopDoc Verified Doctor to ensure that their license is active and they are in good medical standing.

Dr. Linda M Boxer M.D.

Hematologist-Oncologist | Hematology & Oncology

269 Campus Dr Hematology Ccsr 1155 Stanford CA, 94305

About

Dr. Linda Boxer is a hematologist oncologist practicing in Stanford, CA. Dr. Boxer specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.

Education and Training

Stanford Univ Sch Of Med- Stanford Ca 1981

Board Certification

Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology

Internal MedicineAmerican Board of Internal MedicineABIM- 1984

Provider Details

FemaleEnglish 36 years of experience

Expert Publications

Data provided by the National Library of Medicine

Fellowships

  • Stanford University School of Medicine,Stanford, Ca, United States   1989

Publications

  • JAMA : the jourl of the American Medical AssociationClinical interpretation and implications of whole-genome sequencing.2014
  • ONCOGENEFunctiol long-range interactions of the IgH 3 ' enhancers with the bcl-2 promoter region in t(142008
  • NUCLEIC ACIDS RESEARCHProtein/D arrays identify nitric oxide-regulated cis-element2007
  • FASEB jourlTranscription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo.2006
  • FASEB JOURLTranscription factor GATA4 regulates cardiac BCL2 gene expression in vitro and in vivo2006
  • JOURL OF BIOLOGICAL CHEMISTRYRegulatory elements in the immunoglobulin heavy chain gene 3 '-enhancers induce c2005
  • CANCER RESEARCHA genome-wide view of the in vitro response to L-asparagise in acute lymphoblastic leukemia2005
  • Paz-Priel, I., Cai, D. H., Wang, D. H., Heckman, C. A., Gombart, A. F.C/EBP alpha and C/EBP alpha myeloid oncoproteins inhibit apoptosis and induce bcl-2 via D2004
  • JOURL OF NEUROCHEMISTRYNeurotrophin-3 and a CREB-mediated sigling pathway regulate Bcl-2 expression in oligodendrocyte2004
  • JOURL OF BIOLOGICAL CHEMISTRYCytokine-mediated down2003
  • JOURL OF NEUROCHEMISTRYOxidative stress-mediated down-regulation of bcl-2 promoter in hippocampal neurons2003
  • JOURL OF BIOLOGICAL CHEMISTRYImpaired proliferation2002
  • JOURL OF BIOLOGICAL CHEMISTRYA myc-associated zinc finger protein2002
  • METHODSAllele-specific alysis of transcription factors binding to promoter regions2002
  • ONCOGENEThe critical role of the PE21 element in oncostatin M2001
  • MOLECULAR BRAIN RESEARCHThe cyclic AMP response element in the Bcl2001
  • CANCER RESEARCHMolecular mechanisms of transcriptiol control of bcl-2 and c2001
  • EUROPEAN JOURL OF CELL BIOLOGYNerve growth factor-2000
  • JOURL OF BIOLOGICAL CHEMISTRYNF-kappa B activity is required for the deregulation of c2000
  • JOURL OF BIOLOGICAL CHEMISTRYAkt/protein kise B up-regulates Bcl-2 expression through cAMP-response element-binding protein2000
  • JOURL OF BIOLOGICAL CHEMISTRYA-Myb up-regulates bcl-2 through a Cdx binding site in t(14;18) lymphoma cells2000
  • JOURL OF BIOLOGICAL CHEMISTRYInsulin-like growth factor1999
  • JOURL OF BIOLOGICAL CHEMISTRYp53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor1999
  • NUCLEIC ACIDS RESEARCHThe N-termil domain unique to the long form of the Brn1998
  • JOURL OF BIOLOGICAL CHEMISTRYBcl-2 transcription from the proximal P2 promoter is activated in neurol cells by the Brn1998
  • JOURL OF BIOLOGICAL CHEMISTRYThe WT1 protein is a negative regulator of the normal bcl-2 allele in t(14;18) lymphomas1997
  • JOURL OF BIOLOGICAL CHEMISTRYIdentification of the major positive regulators of c1997
  • JOURL OF BIOLOGICAL CHEMISTRYCREB proteins function as positive regulators of the translocated bcl-2 allele in t(141996
  • JOURL OF BIOLOGICAL CHEMISTRYREPRESSION OF THE C-MYB GENE BY WT1 PROTEIN IN T-CELL AND B-CELL LINES1995
  • JOURL OF BIOLOGICAL CHEMISTRYTHE TRANSCRIPTION FACTOR, NM23H21995
  • Ji, L., Arcis, M., Boxer, L. M.NF-KAPPA-B SITES FUNCTION AS POSITIVE REGULATORS OF EXPRESSION OF THE TRANSLOCATED C-MYC ALLELE IN1994
  • JOURL OF BIOLOGICAL CHEMISTRYACTIVATION OF C-MYC EXPRESSION BY C1994
  • ANNUAL REVIEW OF MEDICINETHE ROLE OF ONCOGENES IN HEMATOLOGIC MALIGNCIES1994
  • JAMA : the journal of the American Medical AssociationClinical interpretation and implications of whole-genome sequencing.2014
  • LEUKEMIAThe immunoglobulin heavy chain gene 3 ' enhancers induce Bcl2 deregulation2011
  • ONCOGENEFunctional long-range interactions of the IgH 3 ' enhancers with the bcl-2 promoter region in t(142008
  • NUCLEIC ACIDS RESEARCHProtein/DNA arrays identify nitric oxide2007
  • ONCOGENEThe immunoglobulin heavy-chain gene 3 ' enhancers deregulate bcl-2 promoter usage in t(142007
  • LEUKEMIAActivation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy2007
  • CHEMBIOCHEMArtificial zinc(II) complexes regulate cell cycle and apoptosis-related genes in tumor cell lines2007
  • MOLECULAR AND CELLULAR BIOLOGYRole of the cyclic AMP response element in the bcl-2 promoter in the regulation of endogenous Bcl2006
  • FASEB journalTranscription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo.2006
  • FASEB JOURNALTranscription factor GATA4 regulates cardiac BCL2 gene expression in vitro and in vivo2006
  • ONCOGENEOct transcription factors mediate t(142006
  • Paz-Priel, I., Cai, D. H., Wang, D. H., Kowalski, J., Blackford, A., LC/EBP alpha and C/EBP alpha myeloid oncoproteins induce Bcl2005
  • MOLECULAR CANCER RESEARCHCCAAT/enhancer binding protein alpha2005
  • JOURNAL OF BIOLOGICAL CHEMISTRYRegulatory elements in the immunoglobulin heavy chain gene 3 '-enhancers induce c2005
  • MOLECULAR AND CELLULAR BIOLOGYHistone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(142005
  • CANCER RESEARCHA genome-wide view of the in vitro response to L-asparaginase in acute lymphoblastic leukemia2005
  • Paz-Priel, I., Cai, D. H., Wang, D. H., Heckman, C. A., Gombart, A. F.C/EBP alpha and C/EBP alpha myeloid oncoproteins inhibit apoptosis and induce bcl-2 via DNA2004
  • JOURNAL OF NEUROCHEMISTRYNeurotrophin-3 and a CREB-mediated signaling pathway regulate Bcl-2 expression in oligodendrocyte2004
  • BLOODGene expression patterns associated with recurrent chromosomal translocations2004
  • CANCER RESEARCHCritical elements of the immunoglobulin heavy chain gene enhancers2003
  • ONCOGENERegulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells2003
  • JOURNAL OF BIOLOGICAL CHEMISTRYCytokine-mediated down2003
  • JOURNAL OF NEUROCHEMISTRYOxidative stress-mediated down-regulation of bcl-2 promoter in hippocampal neurons2003
  • JOURNAL OF BIOLOGICAL CHEMISTRYImpaired proliferation2002
  • Fine, B. M., Stanulla, M., Schrappe, M., Ho, M. T., HARBOTT, J., BrownIn childhood acute lymphoblastic leukemia, BCR2002
  • ONCOGENENF-kappa B activates Bcl-2 expression in t(14;18) lymphoma cells2002
  • JOURNAL OF BIOLOGICAL CHEMISTRYA myc-associated zinc finger protein2002
  • METHODSAllele-specific analysis of transcription factors binding to promoter regions2002
  • ONCOGENEThe critical role of the PE21 element in oncostatin M2001
  • Heckman, C. A., Mehew, J. W., Boxer, L. M.The mechanism of bcl-2 activation by NF-kappa B in t(14;18) lymphomas.2001
  • ONCOGENETranslocations involving c-myc and c-myc function2001
  • MOLECULAR BRAIN RESEARCHThe cyclic AMP response element in the Bcl2001
  • CANCER RESEARCHMolecular mechanisms of transcriptional control of bcl-2 and c2001
  • EXPERIMENTAL HEMATOLOGYSuppression of apoptosis2001
  • ONCOGENENegative regulation of bcl-2 expression by p53 in hematopoietic cells2001
  • EUROPEAN JOURNAL OF CELL BIOLOGYNerve growth factor-2000
  • Heckman, C. A., Mehew, J. W., Boxer, L. M.Regulation of Bcl-2 expression by NF-kappa B in t(14;18) lymphoma cells.2000
  • JOURNAL OF BIOLOGICAL CHEMISTRYNF-kappa B activity is required for the deregulation of c2000
  • JOURNAL OF BIOLOGICAL CHEMISTRYAkt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein2000
  • JOURNAL OF BIOLOGICAL CHEMISTRYA-Myb up-regulates bcl-2 through a Cdx binding site in t(14;18) lymphoma cells2000
  • CELL GROWTH & DIFFERENTIATIONThe expression of p53 tumor suppressor gene in breast cancer cells is down1999
  • JOURNAL OF BIOLOGICAL CHEMISTRYInsulin-like growth factor1999
  • FEBS LETTERSA zinc-finger transcription factor induced by TGF1999
  • JOURNAL OF BIOLOGICAL CHEMISTRYp53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor1999
  • NUCLEIC ACIDS RESEARCHActivation of the Bcl-2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade1999
  • Somsouk, L., Heckman, C. A., Mehew, J. W., Kanda, K., Boxer, L. M.An NF-kappa B site in the IgH enhancer deregulates bcl-2 expression in t(14;18) lymphomas.1999
  • Kanda, K., Grandchamps, J., Boxer, L. M.An NF-kappa B site in the IgH enhancer deregulates c-myc expression in Burkitt's lymphoma.1998
  • NUCLEIC ACIDS RESEARCHThe N-terminal domain unique to the long form of the Brn1998
  • JOURNAL OF BIOLOGICAL CHEMISTRYBcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn1998
  • JOURNAL OF BIOLOGICAL CHEMISTRYThe WT1 protein is a negative regulator of the normal bcl-2 allele in t(14;18) lymphomas1997
  • JOURNAL OF BIOLOGICAL CHEMISTRYIdentification of the major positive regulators of c1997
  • MOLECULAR AND CELLULAR BIOLOGYInduction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation1996
  • JOURNAL OF BIOLOGICAL CHEMISTRYCREB proteins function as positive regulators of the translocated bcl-2 allele in t(141996
  • MOLECULAR AND CELLULAR BIOLOGYIdentification of an inducible regulator of c-myb expression during T-cell activation1996
  • JOURNAL OF BIOLOGICAL CHEMISTRYREPRESSION OF THE C-MYB GENE BY WT1 PROTEIN IN T-CELL AND B-CELL LINES1995
  • BLOODMYB BINDING-SITES MEDIATE NEGATIVE REGULATION OF C-MYB EXPRESSION IN T-CELL LINES1995
  • MOLECULAR AND CELLULAR BIOLOGYPI-1 BINDING-SITES ARE NEGATIVE REGULATORS OF BCL-2 EXPRESSION IN PRE-B CELLS1995
  • JOURNAL OF BIOLOGICAL CHEMISTRYTHE TRANSCRIPTION FACTOR, NM23H21995
  • MOLECULAR AND CELLULAR BIOLOGYNF-KAPPA-B SITES FUNCTION AS POSITIVE REGULATORS OF EXPRESSION OF THE TRANSLOCATED C-MYC ALLELE IN1994
  • Ji, L., Arcinas, M., Boxer, L. M.NF-KAPPA-B SITES FUNCTION AS POSITIVE REGULATORS OF EXPRESSION OF THE TRANSLOCATED C-MYC ALLELE IN1994
  • ONCOGENEDIFFERENTIAL PROTEIN-BINDING TO THE C1994
  • JOURNAL OF BIOLOGICAL CHEMISTRYACTIVATION OF C-MYC EXPRESSION BY C1994
  • ANNUAL REVIEW OF MEDICINETHE ROLE OF ONCOGENES IN HEMATOLOGIC MALIGNANCIES1994

Dr. Linda M Boxer M.D.'s Practice location

Dr. Linda Boxer, MD

269 Campus Dr Hematology Ccsr 1155 -
Stanford, CA 94305
Get Direction
New patients: 650-735-4036

Dr. Linda M Boxer M.D.'s reviews

(0)
Write Review

Recommended Articles

  • Lymphoma, the Persistence of Inspirational Women, and the Power of Language

    Each year, Leukemia and Blood Cancer New Zealand (LBC) sponsors their Blood Cancer Patient Forum. They invite speakers to bring them news about such topics as treatment advances and management of cancer from a fully developed psycho-social perspective. Essentially, they dish up good old-fashioned...

  • How is Multiple Myeloma Diagnosed?

    Various tests are conducted for the diagnosis of multiple myeloma since one result of a laboratory test cannot diagnose it alone. A number of factors like the history, complete body check-up, diagnostic test reports and symptoms of the patient are taken into consideration to get a proper diagnosis...

  • Potential Causes of Leukopenia

    IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...

  • Genetic Advancements in Lymphoma Treatment

    Cancers are a huge focus for research. Millions of dollars every year are funneled into funding research that could improve treatment methods or find cures for cancer, including blood cancers. Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL) accounting...

  • Dance Mom Abby Lee Miller Diagnosed with Non-Hodgkin Lymphoma

    Abby Lee Miller, known for her brutal dance instruction and demanding style of training, is as recognized for her tirades as she is for her long-running hit reality show Dance Moms.Abby inherited the love of dance from her late mother and started her own dance company at just 14 years old. She...

  • Facts About Multiple Myeloma

    Multiple myeloma is a certain form of cancer of the plasma cell, which is part of the immune system. It initiates in the bone marrow, where the blood cells are produced.The immune system is made of variety of cells that fight infections and keep the body healthy. What takes place in bone marrow...

Nearby Providers

Nearest Hospitals

STANFORD HEALTH CAREl

300 PASTEUR DRIVE STANFORD CA 94305

Head east 199 ft
Turn right 341 ft
Turn right onto Campus Drive 983 ft
Turn right onto Welch Road 1105 ft
Turn right onto Pasteur Drive 55 ft
You have arrived at your destination, on the left

MENLO PARK SURGICAL HOSPITALl

570 WILLOW ROAD MENLO PARK CA 94025

Head east 199 ft
Turn right 384 ft
Turn left onto Campus Drive 3370 ft
Turn left onto Palm Drive 2931 ft
Continue straight onto University Avenue 851 ft
Continue onto University Avenue 3088 ft
Turn left onto Middlefield Road 2535 ft
Turn right onto Willow Road 3026 ft
Turn right 219 ft
You have arrived at your destination, on the right

LUCILE SALTER PACKARD CHILDREN'S HSP AT STANFORDl

725 WELCH ROAD PALO ALTO CA 94304

Head east 199 ft
Turn right 341 ft
Turn right onto Campus Drive 983 ft
Turn right onto Welch Road 3150 ft
Turn right 348 ft
Turn left 69 ft
You have arrived at your destination, on the left